First Biosimilar Approved to Treat Multiple Sclerosis
FRIDAY, Aug. 25, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announc…
Learn MoreLa tasa de vacunación contra el VPH de los niños de EE. UU. se ha estancado
JUEVES, 24 de agosto de 2023 (HealthDay News) — Por primera vez en una década, la tasa de vacunación contra el virus del papiloma humano (VPH) de los adolescentes de EE. UU. no ha aumentado, muestran unos nuevos datos. Las directrices actuales de los…
Learn MoreLos refuerzos de las vacunas contra la COVID son esenciales para algunos pacientes con cáncer: estudio
JUEVES, 24 de agosto de 2023 (HealthDay News) — Los pacientes con cáncer con unos sistemas inmunitarios debilitados por el tratamiento son uno de los grupos más preocupados por la continua propagación de la COVID-19 y las probabilidades de que la inf…
Learn MoreLas pruebas de aguas residuales de EE. UU. detectan una variante de COVID-19 altamente mutada
JUEVES, 24 de agosto de 2023 (HealthDay News) — Las autoridades de salud pública han detectado la nueva variante BA.2.86 de la COVID-19 en las aguas residuales de EE. UU., lo que plantea preocupaciones sobre la variante, altamente mutada, en Estados …
Learn MoreOxyContin: What It Is, Side Effects, Precautions & Abuse
You may have heard of the painkiller OxyContin and wonder about its pros and cons.To help you better weigh its benefits and risks for pain management, this overview will discuss what OxyContin is, how it’s used, how it’s abused, and its side effects, …
Learn MoreUpdated COVID Vaccines Will Roll Out Mid-September, Officials Say
FRIDAY, Aug. 25, 2023 (HealthDay News) — New COVID-19 booster shots, reworked to target variants circulating now, could be available by mid-September.The U.S. Food and Drug Administration is expected to approve them in a few weeks, CNN reported, citi…
Learn MoreShift Work Tied to Negative Impact on Cognitive Functioning
FRIDAY, Aug. 25, 2023 (HealthDay News) — Shift work may negatively impact cognitive functioning in middle-aged and older adults, according to a study published online Aug. 23 in PLOS ONE.Durdana Khan, Ph.D., from York University in Toronto, and colle…
Learn MoreBus Drivers Faced High Risk of Severe COVID-19
FRIDAY, Aug. 25, 2023 (HealthDay News) — People working in certain jobs had greater risk of being hospitalized for COVID-19, even in the later stages of the pandemic, researchers report. Bus drivers rank high on that list, with double the risk of bei…
Learn MoreMost Patients Have Implantable Penile Prosthesis Coverage
THURSDAY, Aug. 24, 2023 (HealthDay News) — Most patients have coverage for implantable penile prosthesis for erectile dysfunction, with employer exclusion the most common reason for lacking coverage, according to a study published online in the Sept….
Learn MoreNearing Retirement, America’s Lower-Middle Class Faces Increasingly Bad Health
THURSDAY, Aug. 24, 2023 (HealthDay News) — The American middle-class squeeze has grown even worse in recent years, with many in the “forgotten middle” facing financial pressure and poor health as they near retirement age, a new study reports.Essentia…
Learn More